Scinai Immunotherapeutics Ltd - American Depositary Shares — Cash Flow (NASDAQ:SCNI) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -22.56 M-7.87 M-7.26 M-9.38 M-6.33 M-6.03 M — Cash from investing activities -1.84 M-116 K-836 K-637 K-12 K-24 K — Cash from financing activities 4.27 M21.8 M6.78 M1.09 M3.44 M5.77 M — Free cash flow -22.56 M-7.87 M-7.26 M-9.38 M-6.33 M-6.03 M —

News

Why Is Scinai Immunotherapeutics Stock (SCNI) Up Today? - TipRanks.com

Morning News Wrap-Up, 4/24/26: Today’s Biggest Stock Market Stories! - TipRanks.com

Scinai receives expanded grant for robotic manufacturing system

Scinai reports revenue growth as CDMO business expands

Scinai Immunotherapeutics schedules annual meeting for December 22

Scinai receives $246,000 grant to expand biotech manufacturing

Scinai Immunotherapeutics stock soars on promising skin disease drug data

Scinai’s PC111 antibody shows promise for pemphigus treatment

Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn